AMD
Advanced Micro Devices, Inc.
AMD has the edge over GEN overall, supported by stronger modeled upside and stronger fundamentals.
GEN
Gen Digital Inc.
GEN has lower modeled downside risk, despite its lower overall score.
AMD Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
AMD's revenue, profitability, cash flow and balance sheet are all currently strong.
GEN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Stable |
GEN's profitability and cash flow are currently strong, and its revenue and balance sheet are stable.
AMD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 39x | $585 | — |
| Cheap | 40x | $182 | -69% |
| Fair | 112x | $514 | -12% |
| Current | 127x | $585 | — |
| Expensive | 206x | $947 | +62% |
Historical ranges are pointers, not guarantees.
AMD's PE is in its fair range at 127x. If earnings grow as analysts expect, today's price would be 39x next year's earnings, in its cheap range.
GEN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.3x | $16.34 | -45% |
| Forward | 9.5x | $29.69 | — |
| Current | 15x | $29.69 | — |
| Fair | 18x | $35.76 | +20% |
| Expensive | 28x | $54.70 | +84% |
Historical ranges are pointers, not guarantees.
GEN has the edge over AMD in the historical PE scenario, which offers more potential upside but is not a forecast.
AMD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Low |
Analysts expect strong earnings and revenue growth for AMD, with profitability improving. However, they disagree widely on these estimates.
GEN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for GEN, with profitability improving.
AMD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $15.05 | +227% |
| Q3 2026 | $4.60 | +127% |
| Q2 2026 | $3.89 | +122% |
| Q1 2026 | $3.05 | +123% |
| Q4 2025 | $2.65 | +165% |
| Q3 2025 | $2.03 | +81% |
| Q2 2025 | $1.75 | +111% |
| Q1 2025 | $1.37 | +99% |
| Q4 2024 | $1.00 | +89% |
AMD has the edge over GEN on earnings, with more consistent year-over-year improvement.
GEN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.12 | +58% |
| Q3 2026 | $1.98 | +118% |
| Q2 2026 | $1.71 | +78% |
| Q1 2026 | $1.57 | +52% |
| Q4 2025 | $0.96 | -6.8% |
| Q3 2025 | $0.91 | -8.1% |
| Q2 2025 | $0.96 | 0% |
| Q1 2025 | $1.03 | +7.3% |
| Q4 2024 | $1.03 | -53% |
GEN's earnings per share have fallen from their peak: $1.98 over the past year, against $6.20 in mid-2020.
AMD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $13.4B | +45% |
| Q2 2026 | $11.5B | +50% |
| Q1 2026 | $10.3B | +38% |
| Q4 2025 | $10.3B | +34% |
| Q3 2025 | $9.2B | +36% |
| Q2 2025 | $7.7B | +32% |
| Q1 2025 | $7.4B | +36% |
| Q4 2024 | $7.7B | +24% |
AMD has the edge over GEN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | +7.4 points |
| Q2 2026 | 17% | +19 points |
| Q1 2026 | 14% | +3.6 points |
| Q4 2025 | 17% | +5.7 points |
| Q3 2025 | 14% | +3.1 points |
| Q2 2025 | -1.7% | -6.4 points |
| Q1 2025 | 11% | +10 points |
| Q4 2024 | 11% | +5.8 points |
AMD's operating margin was 21% last quarter, up 7.4 points from the same quarter a year ago.
GEN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +12% |
| Q2 2026 | $1.3B | +6.3% |
| Q1 2026 | $1.3B | +27% |
| Q4 2025 | $1.2B | +26% |
| Q3 2025 | $1.2B | +25% |
| Q2 2025 | $1.3B | +30% |
| Q1 2025 | $1B | +4.4% |
| Q4 2024 | $986M | +3.7% |
GEN's revenue has grown year over year every quarter since early 2021: $1.4B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +1.1 points |
| Q2 2026 | 33% | -2.3 points |
| Q1 2026 | 63% | +21 points |
| Q4 2025 | 35% | -3 points |
| Q3 2025 | 36% | -5.4 points |
| Q2 2025 | 35% | -7.7 points |
| Q1 2025 | 41% | -0.1 points |
| Q4 2024 | 38% | +2.7 points |
GEN has the edge over AMD on profitability, with a higher operating margin.
AMD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $554M | -71% |
| Q2 2026 | $1.6B | -9.9% |
| Q1 2026 | $2.6B | +253% |
| Q4 2025 | $2.4B | +118% |
| Q3 2025 | $1.9B | +283% |
| Q2 2025 | $1.7B | +294% |
| Q1 2025 | $727M | +92% |
| Q4 2024 | $1.1B | +351% |
AMD has the edge over GEN on cash flow, with stronger typical year-over-year growth.
GEN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $323M | +202% |
| Q2 2026 | $430M | +6.2% |
| Q1 2026 | $476M | +1.3% |
| Q4 2025 | $535M | +68% |
| Q3 2025 | $107M | -31% |
| Q2 2025 | $405M | +55% |
| Q1 2025 | $470M | -66% |
| Q4 2024 | $318M | +3.6% |
GEN generated $1.8B in free cash flow over the past year, up 36% from the year before.
AMD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +2M shares |
| 1 year | +1.2% | +20M shares |
| 3 years | +2% | +32M shares |
| 5 years | +35% | +431M shares |
| Available history | +40% | +473M shares |
AMD has 1.7B diluted shares, up 1.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $221M |
| Q4 2025 | — |
| Q3 2025 | $89M |
| Q2 2025 | $478M |
| Q1 2025 | $749M |
| Q4 2024 | $256M |
AMD has spent almost nothing on buybacks in the past year.
GEN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -3.4% | -21M shares |
| 3 years | -6.4% | -41M shares |
| 5 years | +2% | +12M shares |
| Available history | -6.8% | -44M shares |
GEN has the edge over AMD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $171M |
| Q2 2026 | $100M |
| Q1 2026 | $200M |
| Q4 2025 | $300M |
| Q3 2025 | — |
| Q2 2025 | $134M |
| Q1 2025 | — |
| Q4 2024 | — |
GEN spent $771M buying back its own shares over the past year, about six times what it spent the year before.
AMD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2020 | -1.0x | Net Cash |
| Q1 2020 | -0.8x | Net Cash |
| Q4 2019 | -1.2x | Net Cash |
AMD has more cash than debt.
GEN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.9x | Moderate |
| Q2 2026 | 3.0x | Moderate |
| Q1 2026 | 3.0x | Elevated |
| Q4 2025 | 3.7x | Elevated |
| Q3 2025 | 3.9x | Elevated |
| Q2 2025 | 4.1x | High |
| Q1 2025 | 3.6x | Elevated |
| Q4 2024 | 3.8x | Elevated |
GEN's net debt is about 2.9 years of its operating earnings (EBITDA), down from 3.9 years a year ago.
AMD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.3 | Neutral |
| Stochastic | 41.4 | Neutral |
AMD's weekly RSI is 59 (neutral) and its Stochastic is 41 (neutral).
GEN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.3 | Neutral |
| Stochastic | 81.3 | Overbought |
GEN's weekly RSI is 59 (neutral) and its Stochastic is 81 (overbought).
AMD PE vs Technology Sector
| Metric | AMD | Sector median | Relative |
|---|---|---|---|
| PE | 127x | 28x | 357% above |
| PE % | 61 | 35 | 26 pts above |
AMD is trading at 127x earnings, a 357% premium to the Technology sector's median of 28x.
GEN PE vs Technology Sector
| Metric | GEN | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 28x | 46% below |
| PE % | 32 | 35 | 3 pts below |
GEN has the edge over AMD on valuation relative to its sector.
AMD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $557.2 | 5.1% above |
| 20 week MA | $525.9 | 11% above |
| 50 week MA | $389.7 | 50% above |
| 100 week MA | $266.9 | 119% above |
| 200 week MA | $199.6 | 193% above |
AMD is in an uptrend: it's above all five of its weekly moving averages, and 193% above its 200-week average.
GEN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.6 | 16% above |
| 20 week MA | $27.2 | 9% above |
| 50 week MA | $25.0 | 19% above |
| 100 week MA | $26.4 | 12% above |
| 200 week MA | $24.2 | 23% above |
GEN is in an uptrend: it's above all five of its weekly moving averages, and 23% above its 200-week average.
AMD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.2 | $91.8 | +99% |
| 2021 | $91.8 | $146.1 | +59% |
| 2022 | $146.1 | $64.5 | -56% |
| 2023 | $64.5 | $147.4 | +128% |
| 2024 | $147.4 | $125.2 | -15% |
| 2025 | $125.2 | $215.0 | +72% |
| 2026 YTD | $215.0 | $585.3 | +172% |
AMD has the edge over GEN on returns for 2026, with the stronger performance.
GEN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $25.6 | $21.0 | -18% |
| 2021 | $21.0 | $25.9 | +23% |
| 2022 | $25.9 | $21.3 | -18% |
| 2023 | $21.3 | $22.8 | +7.1% |
| 2024 | $22.8 | $27.7 | +21% |
| 2025 | $27.7 | $27.8 | +0.4% |
| 2026 YTD | $27.8 | $29.7 | +6.9% |
GEN has finished higher in four of the last six years. It's up 6.9% so far in 2026.